These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 9529324)
1. Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. Solvason N; Wu WW; Kabra N; Lund-Johansen F; Roncarolo MG; Behrens TW; Grillot DA; Nunez G; Lees E; Howard M J Exp Med; 1998 Apr; 187(7):1081-91. PubMed ID: 9529324 [TBL] [Abstract][Full Text] [Related]
2. xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development. Cancro MP; Sah AP; Levy SL; Allman DM; Schmidt MR; Woodland RT Int Immunol; 2001 Dec; 13(12):1501-14. PubMed ID: 11717191 [TBL] [Abstract][Full Text] [Related]
3. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis. Anderson JS; Teutsch M; Dong Z; Wortis HH Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10966-71. PubMed ID: 8855292 [TBL] [Abstract][Full Text] [Related]
4. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2. Woodland RT; Schmidt MR; Korsmeyer SJ; Gravel KA J Immunol; 1996 Mar; 156(6):2143-54. PubMed ID: 8690903 [TBL] [Abstract][Full Text] [Related]
5. xid affects events leading to B cell cycle entry. Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448 [TBL] [Abstract][Full Text] [Related]
6. Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells. Nisitani S; Satterthwaite AB; Akashi K; Weissman IL; Witte ON; Wahl MI Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2737-42. PubMed ID: 10688914 [TBL] [Abstract][Full Text] [Related]
7. B cell production and turnover in CBA/Ca, CBA/N and CBA/N-bcl-2 transgenic mice: xid-mediated failure among pre B cells is unaltered by bcl-2 overexpression. Cancro MP; Sah AP; Levy SL; Allman DM; Constantinescu D; Schmidt MR; Woodland RT Curr Top Microbiol Immunol; 2000; 252():31-8. PubMed ID: 11125490 [TBL] [Abstract][Full Text] [Related]
8. bcl-2 alters the antigen-driven selection of B cells in mukappa but not in mu-only Xid transgenic mice. Kenny JJ; Fischer RT; Lustig A; Dintzis H; Katsumata M; Reed JC; Longo DL J Immunol; 1996 Aug; 157(3):1054-61. PubMed ID: 8757609 [TBL] [Abstract][Full Text] [Related]
9. The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes. Tan JE; Wong SC; Gan SK; Xu S; Lam KP J Biol Chem; 2001 Jun; 276(23):20055-63. PubMed ID: 11274146 [TBL] [Abstract][Full Text] [Related]
10. Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation. Vinuesa CG; Sunners Y; Pongracz J; Ball J; Toellner KM; Taylor D; MacLennan IC; Cook MC Eur J Immunol; 2001 May; 31(5):1340-50. PubMed ID: 11465091 [TBL] [Abstract][Full Text] [Related]
11. Accelerated emigration of B lymphocytes in the Xid mouse. Cariappa A; Kim TJ; Pillai S J Immunol; 1999 Apr; 162(8):4417-23. PubMed ID: 10201977 [TBL] [Abstract][Full Text] [Related]
12. Bruton's tyrosine kinase targets NF-kappaB to the bcl-x promoter via a mechanism involving phospholipase C-gamma2 following B cell antigen receptor engagement. Petro JB; Castro I; Lowe J; Khan WN FEBS Lett; 2002 Dec; 532(1-2):57-60. PubMed ID: 12459462 [TBL] [Abstract][Full Text] [Related]
13. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B. Mizuno T; Rothstein TL J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529 [TBL] [Abstract][Full Text] [Related]
14. Cyclin E and Bcl-xL cooperatively induce cell cycle progression in c-Rel-/- B cells. Cheng S; Hsia CY; Leone G; Liou HC Oncogene; 2003 Nov; 22(52):8472-86. PubMed ID: 14627988 [TBL] [Abstract][Full Text] [Related]
15. Biochemical analysis of the immune B cell defect in xid mice. Lindsberg ML; Brunswick M; Yamada H; Lees A; Inman J; June CH; Mond JJ J Immunol; 1991 Dec; 147(11):3774-9. PubMed ID: 1719087 [TBL] [Abstract][Full Text] [Related]
16. A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse. Klaus GG; Holman M; Johnson-Léger C; Elgueta-Karstegl C; Atkins C Eur J Immunol; 1997 Nov; 27(11):2749-56. PubMed ID: 9394795 [TBL] [Abstract][Full Text] [Related]
17. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells. Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661 [TBL] [Abstract][Full Text] [Related]
18. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction. Santos-Argumedo L; Lund FE; Heath AW; Solvason N; Wu WW; Grimaldi JC; Parkhouse RM; Howard M Int Immunol; 1995 Feb; 7(2):163-70. PubMed ID: 7734414 [TBL] [Abstract][Full Text] [Related]
19. Gene expression profile of B cells from Xid mice and Btk knockout mice. Lindvall JM; Blomberg KE; Berglöf A; Yang Q; Smith CI; Islam TC Eur J Immunol; 2004 Jul; 34(7):1981-91. PubMed ID: 15214046 [TBL] [Abstract][Full Text] [Related]
20. Btk dosage determines sensitivity to B cell antigen receptor cross-linking. Satterthwaite AB; Cheroutre H; Khan WN; Sideras P; Witte ON Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13152-7. PubMed ID: 9371815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]